NCI: SBIR & STTR

The National Cancer Institute is committed to dramatically lessening the impact of cancer.

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs are NCI’s engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer.

The SBIR & STTR Programs are one of the largest sources of early-stage technology financing in the United States. We welcome entrepreneurs and small business leaders to this website to explore grant and contract funding opportunities and a new spirit of collaboration with the NCI.

[Learn More]

Michael Weingarten, Director of the NCI SBIR & STTR Programs discusses how the program began and why it is so important to improving cancer treatments and care for patients.

Connect with us on LinkedIn

The NCI SBIR Development Center is interested in learning more about how SBIR & STTR funding is helping your company to achieve its cancer research goals and business objectives. Please click here to fill out a 'Share Your Story' form, and let us know about any developments with your NCI SBIR- or STTR-funded projects. Learn more about how other successful NCI SBIR & STTR companies are using their funding awards to advance cancer research.

Learn about Funding & Resources Available from the NCI SBIR & STTR Programs

Nature Biotechnology Publishes Article on the SBIR & STTR Programs

In an article published in Nature Biotechnology, SBIR & STTR Development Center staff discuss the application process and provide tips for applying for funding through the SBIR & STTR Programs.

Meet with Leaders from the NCI SBIR Program

Join NCI SBIR Development Center directors in Cambridge, MA, on May 1, 2014, to hear about new opportunities and initiatives that could help your company move one step closer to commercialization.

Register for the presentation and networking lunch by April 30, 2014
Apply for a one-on-one meeting with an SBIR representative by April 17, 2014

Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (SBIR‐IMAT) Funding Opportunity

PAR-13-327
Deadline: May 28, 2014

NCI STTR Administrative Supplements to Accelerate the Development and Commercialization of Cancer–Related Innovations for Phase I and Phase II Awardees.

Deadline: April 21, 2014

Now Available!

Download presentation slides and an audio recording from our exclusive webinar on Direct–to–Phase II Pilot and NCI Phase IIB Bridge Award

2014 SBIR & STTR Omnibus Solicitation:

2014 Receipt dates: August 5 and December 5

2014 SBIR Phase IIB Bridge Solicitation:

RFA-CA-14-002

2014 Receipt date: April 21

2014 SBIR Direct to Phase II Solicitation:

PAR-14-088

2014 Receipt dates: August 5 and December 5